On Thursday April 18, Treeway’s CEO Inez de Greef is a speaker at the Rare Diseases Symposium. The second edition of the Rare Disease Symposium, organized by HollandBIO, is about challenging the status quo and the development of orphan drugs.
Inez will talk about ‘right-to-try’; what does it mean for a patient-driven biotech company?
For more information and to register for the symposium, click on the link.
